Problem statement: Answer the multiple choice question.
Query: Which compound exhibits a 2.703\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
a: COc1ccccc1OCC(=O)OC/C(O)=C(\C#N)c1nc2ccccc2[nH]1
b: O=C1CC(SC2=NCCS2)C(=O)N1c1cccc(Cl)c1Cl
c: COc1cc2c(cc1OC)C(c1cccs1)N(C(=O)C(C)C)CC2
d: Nc1ccn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1.O
e: CC(C)c1[nH]nc2c1C(c1cccnc1)C(C#N)=C(N)O2
Answer: d. Nc1ccn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1.O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Nc1ccn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1.O
Nc1ccn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1.O
4-amino-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one;hydrate